You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
The ID Now COVID-19 test is the second assay from the company to receive EUA from the FDA, following the same designation issued to the Abbott RealTime SARS CoV-2.
The approach, called Lung-CLiP, couples machine learning trained on epigenetic and clonal frequency data with the detection of alterations in blood-borne DNA.
The NxTag CoV Extended Panel is a multiplex PCR test that uses the company's bead-based NxTag technology to detect coronavirus in nasopharyngeal swab specimens.
The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas.
The alliance, led by Singapore-based startup Proteona, also includes several organizations from that city state as well as German research institutes.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.